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Abstract
We developed a new device, the portable gait rhythmogram (PGR), to record up to 70 hrs 
of movement-induced accelerations. Acceleration values induced by various movements, 
averaged every 10 min, showed gamma distribution, and the mean value of this distribu-
tion was used as an index of the amount of overall movements. Furthermore, the PGR 
algorithm can specify gait-induced accelerations using the pattern-matching method. 
Analysis of the relationship between gait-induced accelerations and gait cycle dura-
tion makes it possible to quantify Parkinson’s disease (PD)-specific pathophysiological 
mechanisms underlying gait disorders. Patients with PD showed the following disease-
specific patterns: (1) reduced amount of overall movements and (2) low amplitude of 
gait-induced accelerations in the early stages of the disease, which was compensated by 
fast stepping. Loss of compensation was associated with slow stepping gait, (3) narrow 
range of gait-induced acceleration amplitude and gait cycle duration, suggesting monot-
ony, and (4) evident motor fluctuations during the day by tracing changes in the above 
two parameters. Prominent motor fluctuation was associated with frequent switching 
between slow stepping mode and active mode. These findings suggest that monitor-
ing various movement- and gait-induced accelerations allows the detection of specific 
changes in PD. We conclude that continuous long-term monitoring of these parameters 
can provide accurate quantitative assessment of parkinsonian clinical motor signs.
Keywords: portable gait rhythmogram, gait disorder, gait analysis, wearable device, 
Parkinson’s disease
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1. Introduction
1.1. Why are wearable monitors necessary in clinical management?
Patients with various neurological and musculoskeletal conditions present with a variety of 
gait abnormalities. Parkinson’s disease (PD), parkinsonism-related diseases, and cerebellar 
ataxias show clinically specific features of gait disorders [1–10]. PD is characterized by poverty 
of movements (akinesia) and slowness/smallness of executed movement (bradykinesia) [1–10]. 
Parkinsonian gait disorders are assessed by using clinical score (Unified Parkinson’s Disease 
Rating Scale (UPDRS)) [11], Timed Up and Go testing [12], and gait analysis on short-distance 
walking [10, 13]. However, these methods have limitations regarding exact assessment. First, 
there are dispersions in estimation on UPDRS depending on the examiners. Second, informa-
tion outside the hospital examination rooms is lacking. Finally, gait analysis on short-distance 
walking can be easily influenced by emotional stress caused by increased attention [10, 13].
Proper assessment of the characteristic features of each gait disorder should satisfy two condi-
tions: (1) measure specific kinematic and temporal parameters that reflect deficits in particular 
neural circuitry [13] and (2) measure voluntary control of gait movements continuously over a 
long period of time during activities of daily living (ADL) [1, 5–8]. For these reasons, many types 
of wearable devices that monitor activities including gait have been proposed (see Table 1) 
[14–24]. Maetzler et al. [14] proposed the following clinical features as targets for wearable 
Types of sensors
Devices that mainly monitor overall activities
TricTrac RT3
[9, 20]
Accelerometer- and gyroscope-mounted sensor
Devices that mainly monitor gait disorders
Step watch
[19, 20]
Specific ankle-worn microprocessor-based step counter
DynaPort
[19, 20]
Accelerometer-mounted sensor attached on the trunk
Devices that monitor changes in overall activities and gait disorders
Mobility lab
[21, 22]
Accelerometer- and gyroscope-mounted sensor attached on the limbs 
and trunk
Physiolog
[23]
Accelerometer-, gyroscope-, and barometric pressure-mounted 
sensors attached on the limbs and trunk
AX3
[24]
Accelerometer-mounted sensor attached on the limbs or trunk
Table 1. Features of currently available wearable devices.
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devices: (1) motor disabilities, including axial disability (gait and transfer deficits, freezing 
of gait, imbalance, and frequent falling), bradykinesia in the distal limb, dyskinesia, resting 
tremor, dysarthria, and secondary low activity, and (2) non-motor clinical features, which 
include sleep disturbance and autonomic dysfunction [14]. So far, gait-induced accelerations 
and angular velocities have been used to assess gait akinesia and bradykinesia in PD [14, 25].
1.2. Advantages of accelerometer-mounted wearing device
Accelerometer-mounted devices were originally developed to record all movement-induced 
accelerations [26–29]. Since acceleration-mounted sensors have advantages in quantitative 
assessment of PD-specific changes underlying PD gait disorders, among other types of sen-
sors [14, 15], acceleration signals have recently been analyzed [30–36].
Especially, a series of studies by Weiss and colleagues have clarified the clinical validity of 
quantification of gait-induced accelerations [12, 37–40]. They calculated the gait cycle time 
and the step-to-step variability in PD patients [37–40]. Importantly, the step-to-step variability 
was higher in fallers than non-fallers [37, 38] and in freezers than nonfreezers [39]. They also 
showed that the amplitudes of gait-induced accelerations can be good indices for gait disor-
ders [37–40]. These studies suggest that quantification of gait-induced accelerations, cycles, 
and amplitudes can identify PD-specific changes in gait control. Thus, further development 
of improved algorithm is desirable.
1.3. Proposal of a new algorithm: relationship between gait-induced acceleration 
and gait cycle duration
In order to assess physiologically gait akinesia/bradykinesia in PD, we have developed a new 
system (the portable gait rhythmogram (PGR)) for long-term monitoring of gait-induced 
accelerations during walking and daily routine activity. This system consists of two compo-
nents: the first component is a wearable device with an acceleration sensor, and the second 
one is an automatic gait detection algorithm. Gait-induced accelerations are deduced from 
limb and trunk movements using a mathematical algorithm known as the “pattern-matching 
method” [41–54]. Thus, the PGR can quantitatively identify various movement-induced accel-
erations and gait-induced accelerations, respectively.
In a series of publications, we described the motor signs of patients with PD recorded by the 
PGR [41–54]. Mathematical analysis of various movement-induced accelerations allowed us to 
quantify poverty of movements. Furthermore, examination of gait-induced accelerations clari-
fied two major features of parkinsonian gait: (1) disabilities in force generation and rhythm 
setting and (2) loss of dynamic modulation of the force and rhythm depending on the context. 
By tracing gait fluctuations, it was possible to trace the time and degree of motor fluctuation.
The present article is a review of our published data on the PGR and gait disorders [41–54] 
and proposes a new algorithm that defines the relationship between gait-induced acceleration 
and gait cycle duration so as to quantify comprehensively PD-specific pathophysiological 
mechanisms underlying PD gait disorders.
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2. Identification of gait-induced accelerations using pattern-
matching method and analysis of gait force-rhythm relationship
2.1. Monitoring of motion-induced acceleration
Acceleration signals were measured by a portable PGR equipped with a triaxial accelerom-
eter (Mimamori-gait system, LSI Medience Corporation: size, 75 mm × 50 m × 20 mm; weight, 
120 g) (Figure 1A) [41–54]. The sensor is sensitive not only to dynamic acceleration associ-
ated with rapid body movements but also to those with static acceleration due to gravity. The 
PGR was secured with a fixation belt to the front center of the subject’s waist (predefined posi-
tion) at the start of the study. The subject was instructed to go about her/his daily activities in 
free-living environment for a period of 24 hrs with the device attached at all times except 
when changing clothes or taking a bath. When standing in the anatomical position, the orien-
tation of the three acceleration axes—x, y, and z—was medial/lateral, vertical, and anterior/
posterior, respectively. The rhythmogram measured three-dimensional accelerations (a
x
, a
y
, a
z
) 
associated with limb and trunk movements, as well as those induced by step-in and kickoff dur-
ing gait. Data were collected at a sampling rate (Δt) of 10 ms and stored on a Secure Digital card 
inserted into the device for later analysis using a custom-made software program. A fully charged 
PGR can achieve 70 hrs of continuous recording.
Figure 1. The portable gait rhythmogram device and illustration of the sensor placements (A), Examples of total 
acceleration signal during walking (B), and corresponding cross correlation (solid line), guide wave (dotted line), and 
picked-up peaks (asterisk) (C).
Wearable Technologies28
2.2. Identification of acceleration induced by gait motion
2.2.1. Overview of analytical tools for gait detection
For the analysis of gait characteristics from the three-dimensional acceleration signal, it 
is important to correctly extract the timing of every stride event during walking (hereaf-
ter referred to as stride peak or gait peak). Several basic gait features can be utilized for 
this purpose. First, walking is a repeated body movement and therefore is accompanied 
by rhythmic acceleration patterns. This rhythmicity can be captured by the conventional 
template-matching method [41–44]. Details of the mathematical calculations were reported 
in our previous methodological articles [42–44, 50]. Figure 2 shows a summary diagram of 
the algorithm.
In the present study, the recorded acceleration signal is filtered by a high-pass filter sT
F
/
(1 + sT
F
) to remove slow trends caused by body inclination. The time constant T
F
 is set at 
0.7 sec. From the filtered signal, we choose a three-dimensional (3D) template wave composed 
of p consecutive points:
  [Ax (t + iΔt)  Ay (t + iΔt)  Az (t + iΔt) ] (1)
where  i = 0, 1, … p − 1 .
Then, the normalized cross correlation between this wave and an arbitrary signal segment of 
the same length as the template with a time shift of T is obtained by the following equation:
 
 
1
 __p  ∑ 
i=0
 
p−1
[Ax (t + iΔt) Ax (t + iΔt + T) + Ay (t + iΔt) Ay (t + iΔt + T) + Az (t + iΔt) Az (t + iΔt + T) ] 
       _____________________________________________________________________ 
 { 1 __p  ∑ 
i=0
 
p−1
[Ax  (t + iΔt) 2 + Ay  (t + iΔt) 2 + Az  (t + iΔt) 2 ] } 
 
1
 __2
   { 
1
 __p  ∑ 
i=1
 
p
 [Ax  (t + iΔt + T) 2 + Ay  (t + iΔt + T) 2 + Az  (t + iΔt + T) 2 ] } 
 
1
 __2
 
 . (2)
Here, the average value is subtracted from each acceleration component beforehand. The 
normalized cross correlation characterizes the similarity between two signal segments 
(therefore, the rhythmicity of the signal), offering the basis of self-adaptive algorithm of 
automatic gait peak detection [41–44]. Moreover, this value is a robust measure because it 
is rather insensitive to the manner of setting the coordinate system. This feature is espe-
cially useful in the analysis of long-term acceleration data, since the position or orienta-
tion of the device might be altered from the predefined one during the day; for example, 
it sometimes occurs that the device is worn upside down and/or back to front after the 
patient changes clothes.
We also paid attention to another important feature of gait: biphasicity vs. monophasic-
ity. This means that, during one gait cycle, both vertical and anterior/posterior accelera-
tions change in a biphasic manner, that is, a similar pattern is repeated twice per cycle, 
while medial/lateral acceleration shows a monophasic pattern. The biphasicity/monopha-
sicity inherent in human gait helps to identify correct stride peaks with high precision as 
described below.
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2.2.2. Estimation of continuously walking region
Possible walking regions with stride cycle <2 sec are estimated from the whole time series by 
the following procedure:
• Total acceleration A
r
(t) is calculated from the filtered acceleration components by the 
equation:
•  Ar (t)  =  √ 
___________________
  Ax  (t) 2 + Ay (t) 2 + Az  (t) 2.
• From this time series, local maximum points above a certain threshold are picked up. The time 
indices of these points are hereafter referred to as LMP. The threshold value is typically set to 
1.5 m/s2 to ensure that other cyclic events with low intensity, such as tremor, can be excluded.
• Selection of a template wave is composed of p consecutive points centered at one of those 
LMP, [A
x
(t
0
) A
y
(t
0
) A
z
(t
0
)]. Typically, p is chosen as 50, which corresponds to a time interval 
of 0.5 sec when Δt = 10 msec.
• Calculation of the normalized cross correlation between the template and all signal seg-
ments centered at other LMP, [A
x
(t) A
y
(t) A
z
(t)] for 0 ≤ t-t
0
 ≤ 2 (sec).
• Among the segments with correlation coefficient > 0.5, a segment that yields the highest 
correlation coefficient is selected. The template wave is replaced with this segment wave. 
The existence of a segment with large correlation coefficient (>0.5) strongly suggests that 
the signal within the current time range is highly periodic.
• Procedures (3) and (4) are repeated until no segment waves with correlation coefficient > 0.5 
are found. The central time of the final template thus obtained is denoted as T
1
.
Figure 2. Diagram of the algorithm using the pattern-matching method and analysis of the relationship between gait 
force and rhythm.
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• From the initial t
0
 and the template selected in procedure 2, procedures (3), (4), and (5) 
are repeated backward in time, that is, 0 ≤ t
0
–t ≤ 2. The central time of the final template is 
denoted as T2.
• The region between T2 and T1 is extracted from the acceleration signal. This is an active 
rhythm block characterized by highly rhythmic behavior of moderate or large intensity 
with a cycle duration of <2 sec.
• Procedures (2)–(7) are repeated. In this way, the entire time series is divided into active 
rhythm blocks and inactive and/or nonrhythmic blocks. The former can be regarded as 
continuously walking regions.
2.2.3. Estimation of stride peak candidates
From each of the continuously walking regions, stride peak candidates are estimated by the 
following template-matching algorithm:
• Selection of a point t
0
 from LMP and generation of a template wave with p consecutive 
points centered at this point. The template size p can be typically set to 50, but more pre-
cisely, it should be optimized based on the characteristic timescale of the original accelera-
tion signal [42].
• Calculation of the normalized cross correlation between the template and all signal seg-
ments centered at other LMP.
• Selection of the segments with correlation coefficient > 0.5. Calculation of the average value 
of those correlation coefficients.
• Procedures (1)–(3) are repeated for all LMP. The template wave that yields the largest aver-
age correlation coefficient is chosen as the optimized template.
• Calculation of the normalized cross correlation time series by sliding the optimized tem-
plate over the current continuously walking region.
• Extraction of the local maximum points from the normalized cross correlation time series. 
Among these points, the ones with positive correlation coefficient are the desired stride 
peak candidates.
Hereafter, the time index of the optimized template center is indicated by t
c
.
2.2.4. Detection of stride peaks
The candidate peaks obtained so far are not fiducial points due to the possible presence of 
extra peaks related to the contact of both feet (step peaks) and other spurious points. Therefore, 
stride peaks are determined with the help of a “guide wave” by the following procedure:
• The three-dimensional acceleration signal [A
x
(t) A
y
(t) A
z
(t)] is integrated twice in combina-
tion with high-pass filtering to avoid integration drift. The integrated signal [D
x
(t) D
y
(t) 
D
z
(t)] corresponds to the relative displacement of the body where the device was attached. 
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This operation works to smooth the original signal and enhances the monophasic nature of 
medial/lateral movements during walking.
• (2) Consider a fixed unit vector pointing from [D
x
(t
c
-w) D
y
(t
c
-w) D
z
(t
c
-w)] to [D
x
(t
c
 + w) D
y
(t
c
 + w) 
D
z
(t
c
 + w)] and an arbitrary unit vector pointing from [D
x
(t-w) D
y
(t-w) D
z
(t-w)] to [D
x
(t + w) 
D
y
(t + w) D
z
(t + w)] in 3D space. The inner product of these two vectors is calculated. The in-
ner product is time-dependent, giving a new time series, which is called here “guide wave.” 
Here, the time range of the unit vector w is decided so that the obtained guide wave behaves 
like a square wave with the same monophasic pattern as the medial/lateral (x-axis) signal. 
Usually, it is almost equal to the time range of the optimized template wave, that is, 2w = p.
• Selection of the candidate stride peak with the largest correlation coefficient per single 
guide wave cycle. These are fiducial stride peaks.
The method of making a guide wave is not limited to the one presented here. The key is to 
find a suitable monophasic signal, that is, a signal composed of a wavelet that is repeated 
once per single gait cycle. In [42], we designed a different type of guide wave by utilizing the 
anisotropic character of the x-axis acceleration signal.
Figure 1B and C illustrates the validity of this procedure. Figure 1B shows an example of 
the total acceleration wave. The center point of the optimized template is marked by an open 
circle. The detected peaks using the guide wave are indicated by asterisks in Figure 1C. It is 
clear that only the stride peaks, that is, gait peaks associated with the same leg, are selected, 
while peaks due to the other leg are not counted. In our earlier work, we found that this type 
of peak detection algorithm performs fairly well for the gait of PD patients under supervised 
but non-laboratory conditions, with more than 95% accuracy [43].
2.2.5. Estimation of “gait cycle duration” and “gait-induced acceleration”
After identifying correct stride peaks, the duration of a single gait cycle and the amplitude 
of gait-induced acceleration per cycle are calculated as follows. Let two adjacent stride peaks 
be indexed as i = 1 and i = N. Then, the gait cycle duration is given by  (N − 1) Δt , and gait accel-
eration is defined by   ∑ i=1 
N−1   A 
r
 
 (iΔt) 
 
________
N − 1 . These measures are calculated from all peak-to-peak intervals. Since gait accelerations correlate with floor reaction forces, the amplitude of gait acceleration 
is selected as an index of floor reaction force. Thus, the obtained gait cycle duration and the 
amplitude of gait-related acceleration are averaged for every 10-min period of recording.
2.2.6. Accuracy of analysis using pattern-matching method in detecting gait-induced signals
To further assess the sensitivity of the PGR, we compared the results of PGR with those of a 
standard system using floor reaction forces [unpublished data]. We asked the subject to step 
in response to a particular gait cycle determined by a metronome (0.87–1.30 sec) and com-
pared the reappearance of the cycle recorded from the two devices.
Using the PGR, we recorded metronome-guided 10 m walking in six normal control subjects (age, 
43.3 ± 7.7 years, mean ± SD, four men, and two women). The metronome was set at 92, 100, 112, 
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120, 132, and 138 beats per minute. The subjects were asked to contact the right or left foot cor-
responding to the beat. Thus, the expected gait cycle (the duration from the ground contact of one 
foot to the next contact of the same foot) was 1.30, 1.20, 1.07, 1.00, 0.91, and 0.87 sec, respectively.
In this control study, subjects equipped with the PGR device walked on the force plate (WalkWay 
MW-1000, Anima, Tokyo). Since the force plate was 2.4 m long, only part of the metronome-
guided 10 m walking was recorded simultaneously by the two devices. The gait cycles recorded 
by the two equipments were compared across all subjects and all metronomic paces by using 
the Bland–Altman plot and intraclass correlation (ICC (2,1)) methods. The subjects were asked 
to walk in sync with the beats of the metronome. The cycle of the metronome-guided walking 
was set at five stages: 1.30, 1.20, 1.07, 1.00, 0.91, and 0.87 sec. Figure 3 shows an example of the 
recorded accelerations by PGR during the metronome recording. Figure 3A shows an example 
where a difference was observed between the expected and recorded gait cycles. The expected 
cycle was 0.87 sec, whereas the recorded cycle was 0.94 sec. On the other hand, Figure 3B shows 
an example where the recorded gait cycle matched the expected gait cycle.
Table 2 shows a summary of the gait cycles recorded by the PGR and the force plate, for each 
subject. We could not identify the gait cycle from the force plate data in four cases out of the 
total of 36 measurements. Therefore, we used 32 pairs of data for comparison of the two meth-
ods. Figure 3C shows the Bland–Altman plot, demonstrating the difference in two gait cycles 
as a function of their mean values. The 95% confidence interval of the mean difference was 
[−0.0191 to 0.0003], which includes zero, and no significant regression was observed (p = 0.49), 
Figure 3. (A, B) Examples of gait-induced accelerations during metronome-guided walking. The expected rate defined 
by the metronome was 0.87 sec in (A) and 1.00 sec in (B). (C) Bland–Altman plot of two gait cycles estimated by force 
plate and PGR. The differences between the two sets of gait cycles are plotted against their mean values. The solid line 
represents the mean difference, while the dashed lines are the 95% confidence limit lines (bias ± 1.96 SD).
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suggesting that there was no systematic error in the Bland-Altman plot. Moreover, the two 
gait cycles yielded a fairly high ICC value of 0.98 (p < 0.0001), with 95% confidence interval 
value of [0.96-0.99]. These results indicate that the recorded gait cycle by the PGR was statis-
tically in good agreement with that of the force plate. The results showed no significant dif-
ferences between the two methods, indicating that PGR accurately monitors gait movements 
with sensitivity comparable to that of the force plates. Since more steps were analyzed in the 
recordings using PGR than those using the force plate, fluctuation appears to be small. The 
results of the control experiments indicate that PGR can quantitatively estimate gait disorders 
in daily life with good sensitivity.
2.2.7. Merits of proposed gait measures
One notable merit of the developed method is that both gait cycle duration and gait-induced 
acceleration can serve as quantitative indices for the assessment of daily gait performance. 
Other basic parameters that are widely used in gait analysis are walking speed and step 
length. While these two parameters are not measured directly by our method, it is possible 
to estimate them with good accuracy from the recorded gait measures, since there is a close 
Metronome (beats/min) 92 100 112 120 132 138
Expected gait cycle (sec) 1.30 1.20 1.07 1.00 0.91 0.87
Subject 1
 Force plate (sec) 1.10 1.08 1.08 0.98
 MG-M1100 (sec) 1.18 1.08 1.05 1.04 1.01 0.94
Subject 2
 Force plate (sec) 1.27 1.18 1.00 0.94 0.88 0.84
 MG-M1100 (sec) 1.29 1.19 1.05 0.98 0.90 0.86
Subject 3
 Force plate (sec) 1.24 1.18 1.06 1.02 0.92
 MG-M1100 (sec) 1.28 1.20 1.07 1.00 0.91 0.87
Subject 4
 Force plate (sec) 1.30 1.20 1.06 0.96 0.89 0.87
 MG-M1100 (sec) 1.30 1.20 1.07 1.00 0.91 0.87
Subject 5
 Force plate (sec) 1.28 1.16 1.00 0.96 0.91 0.84
 MG-M1100 (sec) 1.25 1.19 1.07 1.00 0.91 0.87
Subject 6
 Force plate (sec) 1.20 1.08 1.02 0.90 0.84
 MG-M1100 (sec) 1.26 1.20 1.06 1.02 0.91 0.87
Table 2. Recorded gait cycle during metronome-guided walking.
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correlation between (logarithm of) gait-induced acceleration and walking speed, when these 
two parameters are expressed by body height [50].
However, it should be noted that any gait parameter, when used separately, is more than 
often insufficient to allow complete understanding of ambulatory gait behavior. For example, 
a person usually changes gait cycle duration (or cadence) over the course of a day both volun-
tarily and involuntarily. Real life comprises a diversity of environmental constraints, making 
it almost impossible for us to keep on walking freely. Therefore, even if the gait parameter 
appears to deteriorate in a certain time of the day, one cannot decide whether it is caused by 
disorders in internal factors (e.g., the subject’s physical conditions) or by changes in walking 
pace due to external perturbations. In most cases, such “forced” changes are transient, and 
their effects could be reduced by taking the long-time average of the parameter. However, the 
combination of gait cycle duration and gait acceleration provides a more powerful solution to 
this problem, as will be demonstrated in this paper and as was reported previously [43, 44]. 
The two measures, when plotted on a plane, will fall on a rather well-ordered structure that 
is individual-specific and robust against external constraints. The robustness of the gait cycle-
acceleration relationship is considered to result from the human tendency to automatically 
select preprogrammed preferred walking behavior in response to environmental changes 
[43]. Based on this property, we can obtain insightful information on intrinsic gait problems 
from ambulatory monitoring, which is the greatest merit of using the proposed gait measures.
3. Quantification of “poverty of movements” and “slowness/
smallness in executed movements”: “amount of overall movements 
per 24 hrs”
Poverty in movements and slowness/smallness in executed movements are the core motor 
clinical signs of PD. Overall activities should be examined to quantify these two clinical signs. 
In order to quantify overall activities, we analyzed the distribution of 10-min averaged vari-
ous movement-induced accelerations (Figure 4A and B) and calculated the mean value of the 
distribution with the assumption that the curve fits with gamma distribution [45, 53]. The 
gamma distribution is defined by the following formula:
  f (x)  =  x k−1  e −x/θ  / Г (k)   θ k for x > 0 
The mean value was defined as the amount of overall movements per 24 hrs, representing an 
index of poverty of movements and slowness/smallness of executed movements.
A total of 50 patients with PD and 17 normal control subjects participated in this analysis [45]. 
The distribution curve shifted to the left, suggesting a decrease in activities (Figure 4A and B). 
The amount of overall movements per 24 hrs was smaller in PD patients compared with the mean 
value of normal control subjects (0.69 ± 0.19 m/sec2). Furthermore, 38 of the 50 patients (76%) 
showed a decrease below 0.50 m/sec2, the value of mean (1sd). The amount of overall movements 
per 24 hrs decreased in proportion with the severity of PD. The amount of overall movements 
per 24 hrs for patients with score ≥ 30 (0.31 ± 0.09 m/sec2) was significantly lower than that of 
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patients with scores 1–15 (0.40 ± 0.09 m/sec2) (p < 0.05) and that of patients with scores 16–30 
(0.48 ± 0.09 m/sec2) (p < 0.01). Furthermore, in 50 patients with untreated PD, the amount of 
overall movements per 24 hrs was significantly associated with the UPDS part II score and part 
III score [53]. These results suggest that the amount of overall movements per 24 hrs can be a good 
index for poverty of movements and slowness/smallness of executed movements in ADL.
4. Quantitative estimation of parkinsonian gait using two 
parameters: “gait-induced acceleration” and “gait cycle duration”
4.1. Relationship between gait-induced acceleration and gait cycle duration
The relationship between gait-induced acceleration and gait cycle duration (gait acceleration-
cycle duration curves) [45, 46] is shown in Figure 4C and D. Both parameters were recorded 
continuously for more than 24 hrs, and then the average value of every 10 min was computed 
Figure 4. (A, B) Probability distribution of the averaged acceleration per 10 min, obtained from 24 hrs of continuous 
recording. (C, D) examples of gait acceleration-cycle duration relationship in a patient with Parkinson’s disease (PD) 
based on 24 hrs of gait recording. Black thick line: Corresponding regression line. In (C) and (D), red thin line: Regression 
line obtained from the summed average of 17 normal control subjects. The regression line of the PD patient is steep in 
(C), whereas it is flat in (D).
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and plotted. Interestingly, a regression line can be determined for the plotted data. In Figure 
4C and D, the thick black line represents the regression line of data of a PD patient, while the 
thin red line represents the regression line for the data of 17 normal control subjects. The data 
clearly show a correlation between accelerations and cycle; for example, walking with a slow 
cycle is associated with low amplitude of gait accelerations. The slope of the linear regression 
line for data of the normal control subjects was 1.20 ± 0.29.
The gait acceleration-cycle duration curves of PD patients showed two distinct patterns com-
pared to those of normal control subjects [45, 46]. First, the position of the curve in PD devi-
ated from that of the normal control curve; the curve of PD patients was shifted to the left on 
the acceleration axis (Figure 4C and D), suggesting a decrease in the mean amplitude of gait-
induced acceleration. Furthermore, the curve of PD patients was shifted upward (Figure 4C) 
or downward (Figure 4D) on the gait cycle duration axis, suggesting prolongation or shorten-
ing of the mean gait cycle duration, respectively. Second, the range value around the regres-
sion line was narrow in PD patients [45, 46]. A narrow range of acceleration was associated 
with a steep slope of the regression line (Figure 4C), whereas a narrow range of gait cycle 
duration was associated with a flat slope of the regression line (Figure 4D).
Based on these findings, we next quantified these two kinds of changes in the gait acceleration-
cycle duration curve, that is, changes in the mean value and range, as described below.
4.2. Changes in mean values of gait-induced acceleration and gait cycle duration: 
Possible index of PD deficits in gait control neural circuits
We first examined changes in the mean amplitude of gait-induced acceleration and gait cycle 
duration during daily walking in 64 PD patients and 17 normal control subjects [48]. The mean 
values of the gait-induced acceleration and gait cycle duration were computed (Figure 5). PD 
patients walked with significantly lower gait accelerations compared with normal control sub-
jects, but there were no significant differences among the disease stage groups. In contrast, PD 
patients with modified Hoehn and Yahr (mH&Y) stage 1.5 walked with significantly faster 
gait cycle duration (faster rhythm) than those with stages 2.5–3.0 and normal control subjects, 
although there was no significant difference in gait cycle duration between patients with stages 
2.5–3.0 PD and normal control subjects. The lower gait accelerations (i.e., inappropriate force 
production) can be the cause of narrow stride [42, 43]. Thus, the above results suggest that PD 
patients cannot walk with a sufficient stride throughout the clinical course, which can be com-
pensated by increasing stepping [48, 55–57] at the early stage, but not at the advanced stage 
[48]. Our data suggest that computation of acceleration of gait movements and gait cycle dura-
tion from daily walking can be useful in the assessment of the clinical stage of the gait disorder.
4.3. Narrow range of gait-induced acceleration and gait cycle duration: Possible 
index of monotony in PD
Another characteristic change in the shape of the gait acceleration-cycle duration curve is the 
narrowness of the range of force and/or rhythm [45, 46]. When PD patients walked with a nar-
row range of change in gait acceleration (i.e., floor reaction forces), the slope of the regression 
line was steep (steep type) (Figure 4C). In contrast, when PD patients walked with a narrow 
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range of change in the gait cycle duration (i.e., rhythm), the regression line was flat (flat type) 
(Figure 4D). Other patients walked with a narrow range of both acceleration and cycle, and 
their acceleration and cycle duration data were scattered within a narrow range (lump type). 
Under these conditions, the patient always walks with the preferred floor reaction forces or 
cycle, that is, monotone walking.
For quantitative assessment of these changes, we defined %alteration range as an index of 
monotone walking [46]. The mean and standard deviation (SD) of gait acceleration and cycle 
duration were calculated from the gait acceleration-step cycle duration curve, which was con-
structed from a single long-term recording from each patient. Here, we used the SD as an 
index of alteration range. The interindividual mean of SD was calculated from data of 17 
control subjects. Thus, the ratio of the SD of each patient to the interindividual mean of SD of 
the normal control subjects was defined as %alteration range. The cutoff level was set at 75% in 
analysis of the %alteration range.
Changes in %alteration range were examined in 40 patients with PD. In this analysis, the regres-
sion in 16 of the 40 (40%) patients was similar to that of the control (%alteration range > 75%). 
Furthermore, the steep type (%alteration range of gait acceleration of <75%) was identified in 12 
of the 40 patients (30%), whereas the flat type (%alteration range of gait cycle of <75%) was noted 
in 8 of the 20 (20%) patients, and the lump pattern was noted in 10% of patients (4/40) [46].
It has been reported that the maximum activities that can be generated in a muscle burst is 
low in PD patients [58] and that PD patients can only execute movements of different ampli-
tudes at a single, slow velocity without dynamic changes of the movement velocity [59]. These 
studies suggest a possible mechanism for the narrow range of force and rhythm in gait, that 
Figure 5. The mean gait acceleration (A) and mean gait cycle (B) in PD patients according to the modified Hoehn and 
Yahr stages. Differences between each stage group and normal control subjects, and among the stage groups were 
analyzed for statistical significance (*p < 0.05, **p < 0.01, by t-test) [40].
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is, PD patients cannot dynamically vary the force and rhythm in their daily walking, resulting 
in a narrow range of floor reaction forces and step cycles. Our data suggest that quantification 
of both the range of gait-induced acceleration and gait cycle duration provides a useful index 
of monotony, a fundamental pathophysiology in PD.
5. Quantitative estimation of motor fluctuation
Although dopamine replacement therapy is effective at the early stage, patients with PD 
develop motor fluctuation as the disease progresses [13, 47, 60–62]. By detecting changes in 
gait parameters, we tried to determine motor fluctuations. We review here the following two 
methods.
5.1. Method I: identification of “off” by tracing daily changes in gait-induced 
accelerations and gait cycle duration
We traced changes in gait-induced accelerations and cadences (steps/min, a parameter identi-
cal to gait cycle duration). These changes in gait force and rhythm parameters were compared 
simultaneously with patients’ diaries. A total of 44 patients with PD, who showed simultane-
ous changes between accelerations and cadences, and 17 normal control subjects participated 
in this study [47].
No subjective fluctuations were noticed by 23 of these 44 patients. However, the PGR detected 
pathological shift of accelerations and cadences in 19 of the 23 patients (83%). These patients 
showed fast stepping or slow stepping with low amplitude of accelerations. On the other 
hand, the other 21 patients complained of subjective off in their diaries. Long-term tracing 
of gait-induced accelerations and cadences identified no changes in 11 of these 21 patients 
(52%). Surprisingly, no synchronization was noted between the subjective off and gait off 
determined by the PGR in 30 of the 44 patients (68%). This discrepancy could be in part due to 
deficits in attention to motor deficits [63]. Our data suggest that tracing simultaneous changes 
in acceleration and cadence can raise an interesting question: “How do PD patients subjec-
tively notice the off time?”
Clinically, improvements in gait fluctuations of PD patients after the addition or increase in 
dose of an anti-parkinsonism medicine were detected by examining changes in gait force and 
rhythm parameters [54]. The present method had a high sensitivity for detecting improve-
ments than the UPDRS scores.
5.2. Method II: quantitation of degree of motor fluctuation by calculating frequency 
mode change in gait
5.2.1. Two strategies
We reported previously [42, 43] that the relationship between gait-induced acceleration and 
gait cycle duration can be described by the following function derived from an inverted pen-
dulum model:
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where Tc is the gait cycle, av. is the vertical acceleration magnitude averaged over Tc, and α, 
β, and T0 are the three separate parameters. Parameters α and β are subject-specific, represent-
ing a particular walking strategy of an individual, α quantifies how to regulate gait accelera-
tion according to different gait paces, and β is something like a basic potential force that drives 
natural walking. In contrast, T
0
 is assumed to be a constant across subjects. Specifically, we set 
T
0
 = 1.4 sec in order to uncorrelate α and β with each other [42, 43]. The above mathematical 
method was used to build better fitting regression curves from the data. In other words, this 
mathematical method for regression curves represents improvement compared to that shown 
in Figure 4C and D.
Figure 6A shows that two regression lines are necessary for better fitting of plots obtained 
from long-term daily walking, suggesting that a subject usually walks with two types of gait 
mode [49]. The steep regression line with small accelerations for a particular cycle means 
quiet walking, for example, walking within the house, whereas the flat regression line with 
large accelerations for a particular cycle reflects active walking, for example, walking in the 
street. These results suggest that the subject changes the walking strategy during daily walk-
ing between “quiet mode” and “active mode.” To identify the involvement of deficits in 
higher functions, we quantitatively examined the “switching” from one mode to another [49].
5.2.2. Frequency of mode change
A total of 26 patients with PD and 13 normal control subjects participated in this study [49]. 
We introduced the parameter of frequency of mode change (FC), which describes the frequency 
of changes in walking strategies and is calculated mathematically by the following equation:
  FC =  
 ∑ 
t=1
n−1
| I (t + 1) − I (t) |  
  ___________
n − 1 , 
Figure 6. (A) Examples of gait acceleration-cycle duration relationship in a normal subject based on 24 hrs of gait 
recording. The amplitude of gait-related accelerations and duration of gait cycles were plotted for all stride events. 
Two regression lines were required for better fitting. (B) Frequency of mode change (FC) that describes the frequency of 
changes into different walking strategies between quiet mode and active mode.
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where I(t) reflects the walking mode [i.e., active (0) or quiet (1)] in each non-overlapping 
1 hr. interval during the day and t signifies the time index [t = 1, 2, …, n (n ≤ 24)]. FC was 
0.22 ± 0.12 in normal subjects compared with 0.35 ± 0.13 in patients with mild PD (mH&Y stage 
<2.5) and 0.48 ± 0.25 in patients with severe PD (mH&Y stage ≥2.5) (p < 0.05) (Figure 6B) [49]. 
In PD, the quiet mode coincides approximately with slow stepping gait mode. These results 
show that estimation of frequency of change between quiet and active modes provides an 
estimate of the degree of motor fluctuation.
6. Conclusion
Our newly developed wearable device and algorithm, the PGR, allows continuous monitor-
ing of gait for up to 70 hrs and can differentiate precisely gait-induced accelerations from 
other movements. The PGR can monitor both the overall motor activities and gait movements 
in daily activities. The findings obtained from long-term monitoring using PGR are classified 
into three categories.
6.1. Poverty of movements and slowness/smallness of executed movements
Acceleration values induced by various movements, averaged every 10 min, showed gamma 
distribution. The mean value in this distribution was used as an index of the amount of overall 
movements per 24 hrs. The amount of overall movements per 24 hrs was lower in PD patients, espe-
cially in patients with UPDRS-III ≥ 30, suggesting that this parameter reflects the range from 
poverty of movements to slowness/smallness of executed movements.
6.2. Gait disorders
Analysis of the gait acceleration-cycle duration curve provided the mean values and ranges of gait-
induced acceleration and gait cycle duration. Quantitative analysis showed force generation def-
icits, disabilities of gait rhythm setting, and loss of dynamic modulation of the force and rhythm 
in each patient with PD. The quantitative measures can be used for assessment of the degree 
of parkinsonian gait disorders. These changes in gait-induced acceleration reflect PD-specific 
deficits in neural circuits involved in gait control [1, 2, 10]. Thus, it is hoped that long-term moni-
toring of these parameters can identify the pathophysiological changes in gait disorders in PD.
6.3. Motor fluctuation
Furthermore, the device also provides assessment of motor fluctuation from the data of gait 
fluctuation in any particular day. By tracing changes in gait-induced accelerations and gait 
cycle durations, we identified the time of motor off, which was not necessarily noticed by 
patients. Measurement of the frequency of changes in quiet mode (i.e., slow steeping mode) 
and active mode provides information on the degree of severity of motor fluctuation.
6.4. Open questions and possible clinical applications
Taken together, measurement of overall movement- and gait-induced accelerations using a 
wearable device could be useful for clinical assessment of parkinsonian status. Especially, the 
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new algorithm that defines the relationship between gait-induced acceleration and gait cycle 
duration could be useful in clinical applications. However, there are still the following open 
questions:
• Our studies were conducted in a small number of normal subjects and patients with 
PD. Thus, the outcome from our data has not been validated.
• Methodologically, our analysis does not include quantification of stride length. For ex-
ample, analysis using an inverted pendulum model should be useful [64].
Here, we provisionally propose a comprehensive and quantitative examination protocol 
for poverty of movements and slowness/smallness of executed movements, gait disor-
ders, and motor fluctuation in patients with PD using an accelerator-mounted wearable 
device (see Table 3). This physiology-based protocol would make it possible to quantify 
the extent of parkinsonian motor signs and/or the effect of drugs. We anticipate that fur-
ther analysis of daily walking using the PGR would contribute to the development of 
better therapies for PD.
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Quantification of “poverty of movements” and “slowness/ smallness of executed movements”:
• Acceleration values induced by various movements are averaged every 10 min from the long-term monitoring 
data
• The mean value in this gamma distribution can be an index of the amount of overall movements per 24 hrs
Gait disorders:
• Gait-induced accelerations are averaged every 10 min from the long-term monitoring data
• The gait acceleration-cycle duration curve is calculated from these plots
• Changes in the mean values of acceleration and cycle duration can reflect deficits in force production and 
rhythm setting mechanisms, respectively
• Narrowness of accelerations and cycle duration can reflect loss of dynamic modulation of the force and rhythm 
control
Motor fluctuation:
• The time of motor off can be determined by tracing changes in gait-induced accelerations and gait cycle 
durations
• Measurement of frequency of changes between quiet and active modes provides an index of the severity of 
motor fluctuation
Table 3. Protocol for quantitative assessment of poverty of movements and slowness/smallness of executed movements, 
gait disorders, and motor fluctuation.
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